Insights on therapeutic potential of clemastine in neurological disorders

Clemastine, a Food and Drug Administration (FDA)-approved compound, is recognized as a first-generation, widely available antihistamine that reduces histamine-induced symptoms. Evidence has confirmed that clemastine can transport across the blood–brain barrier and act on specific neurons and neurogl...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Sufang, Wang, Xueji, Cao, Tianyu, Kang, Rongtian, Huang, Lining
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Molecular Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568021/
https://www.ncbi.nlm.nih.gov/pubmed/37840769
http://dx.doi.org/10.3389/fnmol.2023.1279985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568021/
https://www.ncbi.nlm.nih.gov/pubmed/37840769
http://dx.doi.org/10.3389/fnmol.2023.1279985

Ejemplares similares